NCT03414060

Brief Summary

This study examines the feasibility and acceptability of the vaginal menstrual cup for short-term management of vesicovaginal fistula (VVF) among 11 women seeking treatment at a health facility in Ghana. The repeated measures design utilizes a 2-hr pad test to compare urinary leakage with and without the insertable cup, a questionnaire on acceptability and perceived effect is administered and a clinical exam is completed. Subsequently, semi-structured interviews will be carried out with up to 24 additional women seeking treatment at a health facility in Ghana. Interviews will cover women's experiences of living with fistula, including strategies for coping with urinary incontinence and resulting stigma, as well as user acceptability to the intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 8, 2016

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 2, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 2, 2016

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

January 19, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 29, 2018

Completed
Last Updated

May 5, 2026

Status Verified

January 1, 2021

Enrollment Period

4 months

First QC Date

January 19, 2018

Last Update Submit

April 29, 2026

Conditions

Keywords

obstetric fistulavesicovaginal fistulamenstrual cuppad testnon-surgical managementfeasibilityacceptabilityinnovationcopingincontinence

Outcome Measures

Primary Outcomes (1)

  • Volume of urinary leakage (in ml)

    Measured by 2-hr pad test

    Over 2 hours

Secondary Outcomes (5)

  • Acceptability of the menstrual cup

    Over 2 hours

  • Adverse events

    Over 2 hours

  • Rate of enrollment through study completion

    through study completion, an average of 1 year

  • Rate of consent through study completion

    through study completion, an average of 1 year

  • Perceived assessment of leakage with use of the menstrual cup

    After 1 hour of use

Study Arms (1)

Intervention (Menstrual Cup)

EXPERIMENTAL

The menstrual cup is a 100% silicone, flexible reservoir cup that, when inserted correctly in the vagina, is sanitary and efficacious in preventing leakage of menstrual blood and in eliminating odor.

Device: Menstrual Cup

Interventions

Intervention (Menstrual Cup)

Eligibility Criteria

Age15 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patient seeking surgical repair for VVF
  • VVF confirmed by gynecologic examination
  • Adequate vaginal capacity to accommodate the menstrual cup
  • Fistula high in vagina (determined at gynecologic examination)
  • Willingness to insert and remove the device by one's self

You may not qualify if:

  • Technically difficult to insert and or remove the menstrual cup (eg severely scarred vagina)
  • Unable or unwilling to learn to insert and remove the menstrual cup
  • Patient who declines consent or is incapable of consent
  • Presence of rectovaginal fistula (RVF) or combined RVF and VVF
  • Fistula low in the vagina precluding collection of urine by the menstrual cup

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mercy Women's Catholic Hospital

Mankessim, Central Region, Ghana

Location

MeSH Terms

Conditions

Vaginal FistulaVesicovaginal FistulaWounds and Injuries

Interventions

Menstrual Hygiene Products

Condition Hierarchy (Ancestors)

Vaginal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsUrinary Bladder FistulaUrinary FistulaUrogenital AbnormalitiesUrinary Bladder DiseasesUrologic Diseases

Intervention Hierarchy (Ancestors)

Feminine Hygiene ProductsEquipment and Supplies

Study Officials

  • Gabriel YK Ganyaglo, MD

    Korle-Bu Teaching Hospital, Accra, Ghana

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: repeated measures
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2018

First Posted

January 29, 2018

Study Start

August 8, 2016

Primary Completion

December 2, 2016

Study Completion

December 2, 2016

Last Updated

May 5, 2026

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will share

Available as supplementary documents in publication

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
The data are available through the publication indefinitely.
Access Criteria
Publication is posted in an open access journal.
More information

Locations